Male contraception - quo vadis?

References

• Hayes FJ, DeCruz S, Seminara SB, Boepple PA, Crowley WF Jr. Differential regulation of gonadotropin secretion by testosterone in the human male: absence of a negative feedback effect of testosterone on follicle-stimulating hormone secretion. J Clin Endocrinol Metab 2001; 86: 53–8.
   Google Scholar
• Illingworth PJ, Groome NP, Byrd W et al. Inhibin-B: a likely candidate for the physiologically important form of inhibin in men. J Clin Endocrinol Metab 1996; 81: 1321–5.
   PubMed Web of Science ®Google Scholar
• Tapanainen JS, Aittomaki K, Min J, Vaskivuo T, Huhtaniemi IT. Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility. Nat Genet 1997; 15: 205–6.
   Google Scholar
• Lindstedt G, Nystrom E, Matthews C, Ernest I, Janson PO, Chatterjee K. Follitropin (FSH) deficiency in an infertile male due to FSHbeta gene mutation. A syndrome of normal puberty and virilization but underdeveloped testicles with azoospermia, low FSH but high lutropin and normal serum testosterone concentrations. Clin Chem Lab Med 1998; 36: 663–5.
   Google Scholar
• Phillip M, Arbelle JE, Segev Y, Parvari R. Male hypogonadism due to a mutation in the gene for the beta-subunit of follicle-stimulating hormone. N Engl J Med 1998; 338: 1729–32.
   PubMed Web of Science ®Google Scholar
• Layman LC, Porto AL, Xie J et al. FSH beta gene mutations in a female with partial breast development and a male sibling with normal puberty and azoospermia. J Clin Endocrinol Metab 2002; 87: 3702–7.
   PubMed Web of Science ®Google Scholar
• Matsumoto AM, Paulsen CA, Bremner WJ. Stimulation of sperm production by human luteinizing hormone in gonadotropin-suppressed normal men. J Clin Endocrinol Metab 1984; 59: 882–7.
   Google Scholar
• Davis KR, Weller SC. The effectiveness of condoms in reducing heterosexual transmission of HIV. Fam Plann Perspect 1999; 31: 272–9.
   PubMedGoogle Scholar
• Fu T, Darroch JE, Haas T, Ranjit N. Contraceptive failure rates. new estimates from the 1995 National Survey of Family Growth. Fam Plan Perspect 1999; 31: 56–63.
   Google Scholar
• Chen C. Postvasectomy pregnancies in China. In: Family Health International and Engender Health, 2001. Durham, NC.
   Google Scholar
• Forste R, Tanfer K, Tedrow L. Sterilization among currently married men in the United States, 1991. Int Fam Plann Perspect 1995; 27: 122.
   Google Scholar
• Chandra A. Surgical sterilization in the United States: prevalence and characteristics, 1965–95. Vital Health Stat 1998; 23: 1–33.
   Google Scholar
• McCullagh EP, McGurl FJ. Further observations on the clinical use of testosterone propionate. J Urol 1939; 42: 1265–7.
   Google Scholar
• Heckel NJ. Production of oligospermia in a man by the use of testosterone propionate. Proc Soc Exp Biol Med 1939; 40: 658–9.
   Google Scholar
• World Health Organization Task Force on Methods for the Regulation of Male Fertility. Contraceptive efficacy of testosterone-induced azoospermia in normal men. Lancet 1990; 336: 955–9.
   PubMed Web of Science ®Google Scholar
• World Health Organization Task Force on Methods for the Regulation of Male Fertility. Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. Fertil Steril 1996; 65: 821–9.
   PubMed Web of Science ®Google Scholar
• Arsyad KM. Sperm function in Indonesian men treated with testosterone enanthate. Int J Androl 1993; 16: 355–61.
   Google Scholar
• Bebb RA, Anawalt BD, Christensen RB, Paulsen CA, Bremner WJ, Matsumoto AM. Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach. J Clin Endocrinol Metab 1996; 81: 757–62.
   PubMed Web of Science ®Google Scholar
• McLachlan RI, O’Donnell L, Stanton PG et al. Effects of testosterone plus medroxyprogesterone acetate on semen quality, reproductive hormones, and germ cell populations in normal young men. J Clin Endocrinol Metab 2002; 87: 546–56.
   PubMed Web of Science ®Google Scholar
• Meriggiola MC, Bremner WJ, Costantino A, Di Cintio G, Flamigni C. Low dose of cyproterone acetate and testosterone enanthate for contraception in men. Hum Reprod 1998; 13: 1225–9.
   Google Scholar
• Anderson RA, Wu FC. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. II. Pharmacokinetics and pharmacodynamics of once weekly administration of testosterone enanthate. J Clin Endocrinol Metab 1996; 81: 896–901.
   Google Scholar
• Zhang FP, Pakarainen T, Poutanen M, Toppari J, Huhtaniemi I. The low gonadotropin-independent constitutive production of testicular testosterone is sufficient to maintain spermatogenesis. Proc Natl Acad Sci 2003; 100: 13692–7.
   Google Scholar
• Anawalt BD, Bebb RA, Bremner WJ, Matsumoto AM. A lower dosage levonorgestrel and testosterone combination effectively suppresses spermatogenesis and circulating gonadotropin levels with fewer metabolic effects than higher dosage combinations. J Androl 1999; 20: 407–14.
   PubMed Web of Science ®Google Scholar
• Wu FC, Balasubramanian R, Mulders TM, Coelingh-Bennink HJ. Oral progestogen combined with testosterone as a potential male contraceptive: additive effects between desogestrel and testosterone enanthate in suppression of spermatogenesis, pituitary-testicular axis, and lipid metabolism. J Clin Endocrinol Metab 1999; 84: 112–22.
   Google Scholar
• Kinniburgh D, Zhu H, Cheng L, Kicman AT, Baird DT, Anderson RA. Oral desogestrel with testosterone pellets induces consistent suppression of spermatogenesis to azoospermia in both Caucasian and Chinese men. Hum Reprod 2002; 17: 1490–501.
   PubMed Web of Science ®Google Scholar
• Anderson RA, Van Der Spuy ZM, Dada OA et al. Investigation of hormonal male contraception in African men: suppression of spermatogenesis by oral desogestrel with depot testosterone. Hum Reprod 2002; 17: 2869–77.
   PubMed Web of Science ®Google Scholar
• Behre HM, Nashan D, Hubert W, Nieschlag E. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception. J Clin Endocrinol Metab 1992; 74: 84–90.
   PubMed Web of Science ®Google Scholar
• Bhasin S, Berman N, Swerdloff RS. Follicle-stimulating hormone (FSH) escape during chronic gonadotropin-releasing hormone (GnRH) agonist and testosterone treatment. J Androl 1994; 15: 386–91.
   Google Scholar
• Pavlou SN, Wakefield GB, Island DP et al. Suppression of pituitary-gonadal function by a potent new luteinizing hormonereleasing hormone antagonist in normal men. J Clin Endocrinol Metab 1987; 64: 931–6.
   PubMedGoogle Scholar
• Tom L, Bhasin S, Salameh W et al. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate. J Clin Endocrinol Metab 1992; 75: 476–83.
   PubMed Web of Science ®Google Scholar
• Behre HM, Klein B, Steinmeyer E, McGregor GP, Voigt K, Nieschlag E. Effective suppression of luteinizing hormone and testosterone by single doses of the new gonadotropin-releasing hormone antagonist cetrorelix (SB-75) in normal men. J Clin Endocrinol Metab 1992; 75: 393–8.
   PubMed Web of Science ®Google Scholar
• Behre HM, Kliesch S, Puhse G, Reissmann T, Nieschlag E. High loading and low maintenance doses of a gonadotropin-releasing hormone antagonist effectively suppress serum luteinizing hormone, follicle-stimulating hormone, and testosterone in normal men. J Clin Endocrinol Metab 1997; 82: 1403–8.
   Google Scholar
• Swerdloff RS, Bagatell CJ, Wang C et al. Suppression of spermatogenesis in man induced by Nal-Glu gonadotropin releasing hormone antagonist and testosterone enanthate (TE) is maintained by TE alone. J Clin Endocrinol Metab 1998; 83: 3527–33.
   PubMed Web of Science ®Google Scholar
• McLachlan RI, McDonald J, Rushford D, Robertson DM, Garrett C, Baker HW. Efficacy and acceptability of testosterone implants, alone or in combination with a 5alpha-reductase inhibitor, for male hormonal contraception. Contraception 2000; 62: 73–8.
   PubMed Web of Science ®Google Scholar
• Kinniburgh D, Anderson RA, Baird DT. Suppression of spermatogenesis with desogestrel and testosterone pellets is not enhanced by addition of finasteride. J Androl 2001; 22: 88–95.
   Google Scholar
• von Eckardstein S, Syska A, Gromoll J, Kamischke A, Simoni M, Nieschlag E. Inverse correlation between sperm concentration and number of androgen receptor CAG repeats in normal men. J Clin Endocrinol Metab 2001; 86: 2585–90.
   PubMedGoogle Scholar
• Eckardstein SV, Schmidt A, Kamischke A, Simoni M, Gromoll J, Nieschlag E. CAG repeat length in the androgen receptor gene and gonadotrophin suppression influence the effectiveness of hormonal male contraception. Clin Endocrinol (Oxf) 2002; 57: 647–55.
   PubMed Web of Science ®Google Scholar
• Handelsman DJ, Farley TM, Peregoudov A, Waites GM. Factors in nonuniform induction of azoospermia by testosterone enanthate in normal men. World Health Organization Task Force on Methods for the Regulation of Male Fertility. Fertil Steril 1995; 63: 125–33.
   Google Scholar
• Santner SJ, Albertson B, Zhang GY et al. Comparative rates of androgen production and metabolism in Caucasian and Chinese subjects. J Clin Endocrinol Metab 1998; 83: 2104–9.
   PubMed Web of Science ®Google Scholar
• Wallace EM, Aitken RJ, Wu FC. Residual sperm function in oligozoospermia induced by testosterone enanthate administered as a potential steroid male contraceptive. Int J Androl 1992; 15: 416–24.
   Google Scholar
• von Eckardstein S, Nieschlag E. Treatment of male hypogonadism with testosterone undecanoate injected at extended intervals of 12 weeks: a phase II study. J Androl 2002; 23: 419–25.
   PubMedGoogle Scholar
• Martin CW, Anderson RA, Cheng L et al. Potential impact of hormonal male contraception: cross-cultural implications for development of novel preparations. Hum Reprod 2000; 15: 637–45.
   PubMed Web of Science ®Google Scholar
• Glasier AF, Anakwe R, Everington D et al. Would women trust their partners to use a male pill? Hum Reprod 2000; 15: 646–9.
   PubMed Web of Science ®Google Scholar